News search

    E.g., 25/11/2024
    E.g., 25/11/2024
    About the CNIC
    6 May 2019
    Nature Communications: A newly identified mechanism can be targeted to boost angiogenesis

    Image: In the picture, individual endothelial cells have different fluorescent barcodes and mitogenic stimulations, allowing the non-invasive fate-mapping of their proliferative and migratory behaviours over time.
    Luis Leiva-Vega, Juan Antonio Bernal, Marta Roche-Molina, Ayelén M. Santamans, Valle Montalvo-Romeral, Aránzazu Pintor-Chocano, Rafael Romero-Becerra, Ainoa Caballero, Alfonso Mora, Guadalupe Sabio, Antonia Tomás-Loba, Marta León, Elena Rodríguez, Juan Antonio López, Jesús Vázquez.
    Research
    11 Apr 2019
    Nature: The protein p38gamma identified as a new therapeutic target in liver cancer

    CNIC scientists have shown for the first time that a protein related to cell stress also regulates cell division
    About the CNIC
    3 Apr 2019
    Adiponectin, the hormone that protects women against liver cancer
    • Adiponectin, secreted by adipose tissue, protects against the development of the main form of liver cancer
    • Women produce the hormone in larger quantities than men, and adiponectin release also declines in people with obesity
    • The results open the route to combating a cancer for which there is currently no treatment and that is the fourth cause of death in the world.
    Dr. José María Mendiguren, Director de Servicios Médicos de Banco Santander, Leticia Fernández-Friera, cardióloga del CNIC y del Hospital Universitario HM Montepríncipe, y Dr. Valentín Fuster, Director del CNIC.
    Research
    26 Mar 2019
    JACC: Advanced imaging technology predicts cardiovascular risk from inflammation detected in arteries

    The results, published in JACC, demonstrate the potential of this technology to generate images of the inflammation associated with systemic atherosclerosis; this information will be useful for the study of early stages of this disease and will help to identify individuals who will benefit from early medical intervention
    Pilar Gonzalo, Rosa Nevado, Ricardo Villa-Bellosta, Magda R. Hamczyk, María J. Andrés-Manzano, and Vicente Andrés.
    Research
    12 Mar 2019
    EMBO Molecular Medicine: CNIC scientists discover a new therapeutic target for blocking early atherosclerosis in progeria

    This new results, published in EMBO Molecular Medicine, identify a possible therapeutic target for this genetic disease
    Borja Ibáñez, Carlos Galán, Rodrigo Fernández, Eduardo Oliver, Gonzalo Pizarro, Manuel Lobo, Jean Paul Vilchez Tschischke, Antonio de Molina-Iracheta, Rocío Villena y Javier Sánchez-González
    Research
    19 Feb 2019
    JACC: Identified a very early marker of cardiac damage triggered by cancer treatment

    The results have implications for patient prognosis, since detection of this marker can prompt intervention to prevent irreversible damage
    Andrés Hidalgo y José María Adrover+
    Research
    30 Jan 2019
    Immunity: Scientists discover an immune “clock” that controls infections and cardiovascular disease

    Neutrophils are the body’s main line of defense, but their action can also damage healthy cells in the cardiovascular system
    Annalaura Mastrangelo, David Sancho, Salvado Iborra, María Martínez-López y Ruth Conde Garrosa.
    Research
    30 Jan 2019
    Immunity: Scientists identify a new "watchdog" that controls intestinal bacteria

    The study, published in Immunity, shows that some intestinal bacteria, such as Lactobacillus, strengthen the intestinal barrier by interacting with an immune cell receptor called Mincle (Clec4e)
    About the CNIC
    18 Jan 2019
    The Pro CNIC Foundation extends its commitment with the CNIC until 2028
    • ·         The Pro CNIC Foundation prolongs its commitment until 2028, with the excellent cardiovascular research carried out at the CNIC under the management of Dr. Valentín Fuster
    • ·         The innovative public-private financing formula has allowed the CNIC to reach a very high level of excellence, making it worthy of the Severo Ochoa accreditation and other international recognitions 
    • The Pro CNIC joins together 12 of the most important companies in Spain: Acciona, Santander Bank, BBVA, Endesa, Mapfre Foundation, Mutua Madrileña Foundation, Ramón Areces Foundation, Repsol Foundation, Inditex, "la Caixa", Prisa and Telefónica.
    Research
    16 Jan 2019
    JACC: The duration and quality of sleep is of vital importance in cardiovascular health

    Poor quality sleep increases the risk of atherosclerosis according to the PESA CNIC- Santander Study published in the Journal of the American College of Cardiology (JACC)